According to Alnylam Pharmaceuticals 's latest financial reports and stock price the company's current number of shares outstanding is 124,111,000. At the end of 2023 the company had 124,111,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.12 B | 0.69% |
2022 | 0.12 B | 2.92% |
2021 | 0.11 B | 3.01% |
2020 | 0.11 B | 4.05% |
2019 | 0.11 B | 10.57% |
2018 | 0.10 B | 5.12% |
2017 | 96.13 M | 11.99% |
2016 | 85.84 M | 1.15% |
2015 | 84.87 M | 10.28% |
2014 | 76.95 M | 22.33% |
2013 | 62.9 M | 21.4% |
2012 | 51.82 M | 21.49% |
2011 | 42.65 M | 1.26% |
2010 | 42.12 M | 1% |
2009 | 41.7 M | 1.24% |
2008 | 41.19 M | 5.57% |
2007 | 39.02 M | 21.49% |
2006 | 32.12 M | 53.59% |
2005 | 20.91 M | 7.21% |
2004 | 19.5 M | 2209.85% |
2003 | 0.84 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
![]() Novartis NVS | 2,110,000,000 | 1,600.09% | ๐จ๐ญ Switzerland |
![]() Sanofi SNY | 2,508,000,000 | 1,920.77% | ๐ซ๐ท France |
![]() Regeneron Pharmaceuticals REGN | 107,100,000 | -13.71% | ๐บ๐ธ USA |
![]() Sarepta Therapeutics
SRPT | 88,186,000 | -28.95% | ๐บ๐ธ USA |
![]() Regulus Therapeutics RGLS | 16,839,700 | -86.43% | ๐บ๐ธ USA |
![]() OPKO Health
OPK | 751,506,257 | 505.51% | ๐บ๐ธ USA |
![]() Teva Pharmaceutical Industries TEVA | 1,111,000,000 | 795.17% | ๐ฎ๐ฑ Israel |
![]() Arrowhead Pharmaceuticals
ARWR | 106,757,000 | -13.98% | ๐บ๐ธ USA |